Action for access
More and more people across Europe are finding it hard to access high-quality cancer care in the wake of years of public spending cuts. This Editorial looks at some initiatives to address growing inequalities and [more]
high-quality cancer care
Personalised medicine: a note of caution
Tailoring a patient’s treatment to the particular biology of their cancer holds out the enticing prospect of avoiding over-treatment and reducing unnecessary toxicity. But delivering the right option for the right patient at the right [more]